Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Scion Life Sciences is a New York City-based venture capital firm specializing in life sciences. Founded to build biotechnology companies, it focuses on developing clinically transformational or curative medicines. The firm comprises experienced innovators and investors dedicated to improving human health.
Scion Life Sciences invests in biotechnology companies addressing clinically important problems. Their disciplined investment strategy is guided by three pillars: mature modality, well-understood biology and pathophysiology, and standalone viability. The firm prioritizes creating important new medicines over focusing solely on exits.
Scion Life Sciences has founded or built ten companies over the past decade, advancing over 15 clinical-stage therapeutics. These companies have collectively generated more than $14 billion in public equity value and announced M&A proceeds.
Email info@scionlifesciences.com with your deck to pitch them.
Yes, Scion Life Sciences often leads investment rounds in the biotechnology sector, focusing on companies that align with their clinical impact goals.
The firm is open to follow-on investments, particularly in companies that demonstrate significant clinical progress and potential for impactful new medicines.
Specific details about the size of Scion Life Sciences' current fund are not publicly available.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.